US · Healthcare

Ironwood Pharmaceuticals Inc (IRWD)

Drug Manufacturers - Specialty & Generic

Ironwood Pharmaceuticals Inc (IRWD) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IRWD

P/E ratio

18.00

Ironwood Pharmaceuticals Inc (IRWD) — FAQ

What is IRWD's P/E ratio?

The price-to-earnings (P/E) ratio for Ironwood Pharmaceuticals Inc (IRWD) is 18.00 (data as of 2026-05-24).

Does Ironwood Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Ironwood Pharmaceuticals Inc (IRWD). Check the MyAverix Finance app for the latest dividend data.

What sector is Ironwood Pharmaceuticals Inc in?

Ironwood Pharmaceuticals Inc (IRWD) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is IRWD listed on?

IRWD is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)